Medical Termination of Pregnancy — Indian Legal Framework
Admission & discharge
Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.
When admission or continued hospital care is needed
- Admit haemorrhage, infection, severe uncontrolled pain, suspected ectopic pregnancy, major comorbidity or a procedure/gestation requiring hospital monitoring.
When clinic, day care or home care may be suitable
- Use a legally authorised service and a method/setting appropriate to gestation, health, safeguarding needs and preference; uncomplicated early care may be outpatient.
Before going home
- Clinical recovery and bleeding/pain are satisfactory; treatment completion or the agreed way of confirming completion is documented.
- Written information, emergency access and any planned follow-up/test are provided. Routine follow-up is not mandatory after uncomplicated care if adequate instructions and access are available (WHO).
Discharge medicines and treatment changes
- Supply the method-specific medicines, pain relief and any indicated prophylaxis exactly as prescribed. Offer contraception if wanted; do not infer RhD or antibiotic requirements from an unrelated procedure.
Medicine doses — use only when indicated
Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.
Analgesia when suitable; method-specific abortion regimens remain in Treatment.
- Indication: Short-term maternal postoperative/postpartum pain or other mild pain after assessment; adult ≥50 kg
- MSF oral monograph: no pregnancy or breastfeeding contraindication. The dose does not replace assessment of the cause of pain.
- Pain and functional recovery; investigate increasing pain, fever or other warning symptoms.
- Check all prescribed/OTC paracetamol, weight and hepatic risk; suspected excess dosing requires urgent assessment.
Tests, pending results and their reviewer
- Record any pathology, testing or completion check that actually needs follow-up; make a clear plan for ongoing-pregnancy symptoms or uncertain completion.
Home care and counselling
- Explain expected bleeding/pain, how to access help, fertility return and contraceptive choices without making contraception a condition of discharge.
Follow-up: when and what to review
| When | Action / responsible service |
|---|---|
Before leaving | Agree whether follow-up is required, what test is used and who reviews it; provide emergency contacts. |
If recovery is not as explained | Arrange review promptly; persistent pregnancy symptoms, little/no bleeding after medical treatment or an abnormal scheduled test requires contact. |
Return urgently
- Heavy/prolonged bleeding, collapse, fever, offensive discharge or severe/persistent pain needs urgent assessment.
Treatment
① Immediate stabilization — first minutes
Clinical emergencies override paperwork: life-saving termination permitted at ANY gestation — document contemporaneously.
② Assessment & investigations
- Confirm gestation (LMP + earliest US; late-presenters: biometry dating note)
- Exclude ectopic before medical abortion
- CBC/Rh; bleeding profile where indicated
③ First-line treatment & drug regimens
- MEDICAL ABORTION (≤9 wks typical MMA window per provider norms; WHO supports up to 12 wks outpatient where legal): mifepristone 200 mg PO day 1 → misoprostol 800 µg PV/SL 24–48 h later → confirm expulsion; add 400 µg SL q3h if needed
- MEDICAL ABORTION >9–12 wks (facility-based): misoprostol 800 µg PV then 400 µg SL/PV q3h until expulsion (or mifepristone priming improves efficacy)
- SURGICAL: MVA ≤12 wks; D&E 13+ wks (trained provider, osmotic dilators overnight)
④ Drug treatment detail (2 agents)
- Indication: Priming for a combined medical-abortion course <12 weeks, within the legal and service framework
- A single dose does not require a routine breastfeeding interruption in the cited MSF monograph.
- Bleeding, pain, ongoing pregnancy symptoms and access to urgent review
- Indication: After appropriate eligibility, pregnancy-location assessment and consent; comply with India MTP law and approved service arrangements
- Expected bleeding/pain, heavy bleeding, infection signs and pregnancy resolution; persistent pain or symptoms requires ectopic assessment
Definitive treatment
Confirmed complete evacuation + stable vitals + contraception initiated = episode complete.
Monitoring
- Expulsion confirmation (products seen/US if doubt)
- Follow-up visit 1–2 wks or urine hCG at 3 wks
- Bleeding patterns explained (up to 2–4 wks light loss normal)
Treatment failure
- Ongoing pregnancy after MA → surgical completion (misoprostol exposure is not a teratogenic contraindication but completion required)
- Retained tissue with heavy bleeding → MVA
Procedure / surgery
See procedure pages: Medical Methods of Abortion and MVA/D&E (linked).
Escalation
- Complications (perforation/haemorrhage/sepsis) managed per respective emergency modules
⑮ Complications & their management
Incomplete abortion
Re-dose misoprostol or MVA
Haemorrhage
Uterotonics + evacuation ± balloon
Infection
Antibiotics per vaginitis/PID severity ladder
Undiagnosed ectopic
Ectopic pathway immediately
Post-treatment care
- CONTRACEPTION SAME DAY (PPIUCD implant DMPA POP all compatible)
- Anti-D for Rh-negative (250 IU <12 wks / full dose later)
- Psychological support; confidentiality assured (statutory)
- Legal register completed; Forms filed
Diagnosis & assessment
Definition: The Medical Termination of Pregnancy Act 1971 as amended 2021, plus MTP (Amendment) Rules 2021, govern lawful termination in India. Termination must occur at a Government hospital or approved facility (Section 4).
Principles & follow-up
Management principles
Special situations
| Provision | Requirement |
|---|---|
≤20 weeks gestation | Opinion of ONE registered medical practitioner formed in good faith (risk to life/physical or mental health incl. rape anguish presumption; substantial foetal abnormality risk) |
>20–24 weeks (Rule 3B categories) | Opinion of TWO registered medical practitioners. Categories: survivors of sexual assault/rape/incest; minors; change of marital status during pregnancy (widowhood/divorce); major physical disability (RPwD Act 2016 criteria); mental illness including retardation; foetal malformation with substantial risk of incompatibility with life/serious handicap; humanitarian/disaster settings declared by Government |
>24 weeks (any category) | ONLY where substantial foetal abnormality diagnosed by STATE MEDICAL BOARD (gynaecologist + paediatrician + radiologist/sonologist + others). Board opinion within 3 DAYS of request (Form D); procedure performed within 5 DAYS of Board advice |
No gestational limit | Where termination necessitated by risk to LIFE of pregnant woman |
Provider norms (Rule 4 ca) | Medical methods up to 9 weeks: RMP with ≥3 months OBG hospital experience OR 10 supervised MMA cases; surgical limits per Rules |
Confidentiality (Section 5A) | Name/particulars must NOT be revealed except to person authorised by law — punishable (imprisonment up to 1 year/fine/both) |
Place (Section 4) | Government hospital OR facility approved by Government |
Sources (9)
Act assent 2021-03-25, in force 2021-09-24; Rules notified 2021-10-12 · checked 2026-08-23 · verified-live
Open source ↗
Official Gazette text + SCC/LiveLaw notifications; Section 5A confidentiality (disclosure punishable up to 1 yr); place-of-performance restriction s.4; failure-of-device presumption explanation; rape anguish presumption Explanation 2
· checked 2026-10-17 · verified-summary
Open source ↗
Recommendation 27: <12-week mifepristone 200 mg followed 24–48 hours later by misoprostol 800 micrograms; route options and no fabricated universal maximum for repeat doses. India legal/service eligibility remains separate.
· checked 2026-10-18 · verified-live
Open source ↗
Primary public information read: expected recovery, bleeding/pain, infection or continuing-pregnancy concerns, follow-up access and contraceptive counselling; used with WHO abortion guidance, without inventing a mandatory visit after every uncomplicated abortion.
· checked 2026-10-18 · verified-live
Open source ↗
Full primary oral monograph read: adult 1 g 3–4 times daily, maximum 4 g/day, ≥50 kg adult table, 500 mg tablets, duration according to response, hepatic caution and pregnancy/breastfeeding. Pain chapter also checked for 6–8-hour interval. Smaller adults require an individual weight-based prescripti…
· checked 2026-10-18 · verified-live
Open source ↗
Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.
· checked 2026-10-18 · verified-live
Open source ↗
Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.
· checked 2026-10-18 · verified-live
Open source ↗
Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.
· checked 2026-10-18 · verified-live
Open source ↗
Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…
· checked 2026-10-18 · verified-live
Open source ↗
Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.